Search results
3 Top Stocks I'd Buy Today and Hold Forever Without Any Hesitation | The Motley Fool
The Motley Fool· 6 days agoWhat's necessary is a rock-solid business model that's already withstood different turns of the...
CRISPR Therapeutics Stock (NASDAQ:CRSP): Will It Take Off Anytime Soon?
TipRanks via Yahoo Finance· 4 days agoDespite my optimism about the long-term prospects of curative gene therapy and CRISPR Therapeutics...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 2 days agoIn terms of fundamental and technical metrics, the best biotech stocks trading above 10 right now...
Stocks Show Signs of Buyer Exhaustion After Rally: Markets Wrap
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- Stocks retreated after a rally to all-time highs spurred calls for a near-term...
Forget Eli Lilly, Buy This Magnificent Biotech Stock Instead | The Motley Fool
The Motley Fool· 3 days agoNearly everything is going right these days for Eli Lilly (LLY -0.24%). The drugmaker has more room...
Autodesk Stock Jumps As Activist Investor Pushes For Margin Improvement, Board Changes: The Details...
Benzinga· 7 days agoAutodesk Inc ADSK shares are trading higher Monday after activist investor Starboard Value purchased...
Meet This Year’s Top CEOs. They Aced a Tough Job, but Aren’t Resting on Their Laurels.
Barrons.com· 2 days agoHis biggest challenge now is making enough of it. Shares have multiplied 11-fold in price since he...
Equities Research Analysts’ Price Target Changes for June 17th (ACN, AMAT, AMH, ARM, ASML, AVB,...
ETF DAILY NEWS· 7 days agoEquities Research Analysts’ price target changes for Monday, June 17th: Accenture (NYSE:ACN) had its...
Should You Invest in the VanEck Biotech ETF (BBH)?
Zacks via Yahoo Finance· 7 days agoETF has heaviest allocation in the Healthcare sector--about 100% of the portfolio. Looking at individual holdings, Amgen Inc (AMGN) accounts for about...
In drug-pricing debate, Mass. gene-therapy drugmakers make their case - Boston Business Journal
The Business Journals· 3 days agoWhen a new gene therapy to treat a deadly rare disease called metachromatic leukodystrophy was approved earlier this year, the first thing on Maria Kefalas’ mind wasn’t the price. Kefalas' daughter ...